Entyvio 300 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FMEJ5
Awardee
Awarding agency
Obligated
$49,663

Award facts

Contract value 100% obligated
$49,662.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, with a ceiling value of $49,662.50, for supply of Entyvio 300 mg vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. The delivery order was issued under the company's single-award Indefinite Delivery Contract with DLA, designated SPE2DR, which carries a $499.99 million ceiling and extends through December 31, 2036. Place of performance is Park Ridge, IL. Ultimate completion date for this delivery order is February 10, 2026.

Quick answers

Who was awarded contract SPE2DR26FMEJ5?

SPE2DR26FMEJ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 9, 2026.

How much is contract SPE2DR26FMEJ5 worth?

The government has obligated $49,663 on SPE2DR26FMEJ5.

Is contract SPE2DR26FMEJ5 an order under another contract?

Yes. SPE2DR26FMEJ5 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.

Was contract SPE2DR26FMEJ5 competed?

The extent of competition for SPE2DR26FMEJ5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award